WebHowever, this difference was not statistically significant (P=.12). In group 2, the intraocular pressure in the apraclonidine-treated eyes when the fellow eyes had been treated with brimonidine was 10.2±2.4 mm Hg. The intraocular pressure in the same eyes when placebo had been instilled in both eyes was 12.8±2.5 mm Hg, a difference of 20% (P ... WebBrimonidine tartrate and Timolol maleate is an an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor that is FDA approved for the treatment of glaucoma, ocular hypertension; in patients requiring adjunctive or replacement therapy.
glaucoma and ocular hypertension dorzolamide for …
WebJul 7, 2004 · Results: There was no statistically significant difference between the brimonidine 0.2% and brimonidine Purite 0.15% groups with respect to mean IOP at baseline. The IOP-lowering efficacy of brimonidine Purite 0.15% was equivalent to that of brimonidine 0.2% and both study treatments maintained IOP-lowering effects of … WebWhen given brimonidine tartrate 0.2% first before switching to brimonidine-Purite 0.15%, 85% preferred brimonidine-Purite 0.15% (P=.001). The results of this study suggest that brimonidine-Purite 0.15% is significantly more comfortable than brimonidine tartrate 0.2% in patients with irritated eyes. Publication types Clinical Trial rajini teledrama
Brimonidine-purite 0.1% versus brimonidine-purite 0.15
WebIn solution, Brimonidine Tartrate Ophthalmic Solution, 0.15% has a clear, greenish-yellow color. It has an osmolality of 250 – 350 mOsmol/kg and a pH of 6.6-7.4. Each mL of … WebNew formulations of brimonidine contain brimonidine tartrate 0.1 or 0.15% in a buffered solution of pH 6.6–7.4 preserved with Purite‡ 0.005%15. Although the new formulations contain a reduced concentration of brimonidine, they were shown in clinical trials to have the same IOP-lowering efficacy and better dreadnaw v